The value of multimodal treatment in anaplastic thyroid cancer patients with distant metastasis

BMC Surg. 2024 Mar 4;24(1):79. doi: 10.1186/s12893-024-02375-6.

Abstract

Background: Anaplastic thyroid cancer (ATC) is a rare and aggressive malignancy with a poor prognosis, particularly in patients presenting with distant metastasis (DM). This study aimed to assess the effect of combination treatment strategies on survival in ATC patients with DM.

Methods: A retrospective analysis was conducted using data from the Surveillance, Epidemiology, and End Results (SEER) database to identify primary ATC cases with DM at diagnosis. Univariate and multivariate Cox proportional hazards regression analyses were performed to identify independent risk factors for survival.

Results: Of the 315 ATC patients with DM included in the study, surgery to the primary tumor, radiotherapy, chemotherapy, and lung metastasis were identified as independent risk factors for survival. Patients who received primary tumor surgery plus chemotherapy or surgery plus chemoradiation exhibited a superior outcome compared to those who received only one treatment modality.

Conclusion: Our findings suggest that a combination treatment approach, particularly surgery combined with radiotherapy or surgery combined with chemoradiotherapy, may provide the most optimal treatment option for ATC patients with DM. These results may provide some evidence for clinical decision making, but larger sample cohorts are still needed for validation.

Keywords: Anaplastic thyroid Cancer; Combination treatment; Distant metastasis; Prognosis.

MeSH terms

  • Chemoradiotherapy
  • Combined Modality Therapy
  • Humans
  • Retrospective Studies
  • Thyroid Carcinoma, Anaplastic* / therapy
  • Thyroid Neoplasms* / therapy